S100A8 and pancreatic neoplasm: Importantly, elevated levels of S100A8 and S100A9 were found in the ductal fluid of patients with pancreatic cancer, and the high expression levels of both proteins were associated with a median survival time that was nearly halved in comparison with that of patients without similarly elevated levels.